EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Novel HSA-PMEMA Nanomicelles Prepared via Site-Specific In Situ Polymerization-Induced Self-Assembly for Improved Intracellular Delivery of Paclitaxel

Yang Chen, Shuang Liang, Binglin Chen, Fei Jiao, Xuliang Deng iD, Xinyu Liu iD

Pharmaceutics · 01.03.2025 · 17 (3) · 316

DOI: 10.3390/pharmaceutics17030316 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 01.03.2025. Verfasst von Yang Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medical Technology, Peking University Health Science Center, Beijing 100191, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, NSFC/China, Clinical Medicine Plus X - Young Scholars Project, Peking University, the Fundamental Research Funds for the Central Universities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Paclitaxel (PTX) is a potent anticancer drug that is poorly soluble in water. To enhance its delivery efficiency in aqueous environments, amphiphilic polymer micelles are often used as nanocarriers for PTX in clinical settings. However, the hydrophilic polymer segments on the surface of these micelles may possess potential immunogenicity, posing risks in clinical applications. To address this issue, nanomicelles based on human serum albumin (HSA)–hydrophobic polymer conjugates constructed via site-specific in situ polymerization-induced self-assembly (SI-PISA) are considered a promising alternative. The HSA shell not only ensures good biocompatibility but also enhances cellular uptake because of endogenous albumin trafficking pathways. Moreover, compared to traditional methods of creating protein–hydrophobic polymer conjugates, SI-PISA demonstrates higher reaction efficiency and better preservation of protein functionality.

Methods

We synthesized HSA-PMEMA nanomicelles via SI-PISA using HSA and methoxyethyl methacrylate (MEMA)—a novel hydrophobic monomer with a well-defined and stable chemical structure. The protein activity and the PTX intracellular delivery efficiency of HSA-PMEMA nanomicelles were evaluated.

Results

The CD spectra of HSA and HSA-PMEMA exhibited similar shapes, and the relative esterase-like activity of HSA-PMEMA was 94% that of unmodified HSA. Flow cytometry results showed that Cy7 fluorescence intensity in cells treated with HSA-PMEMA-Cy7 was approximately 1.35 times that in cells treated with HSA-Cy7; meanwhile, HPLC results indicated that, under the same conditions, the PTX loading per unit protein mass on HSA-PMEMA was approximately 1.43 times that of HSA. These collectively contributed to a 1.78-fold overall PTX intracellular delivery efficiency of HSA-PMEMA compared to that of HSA.

Conclusions

In comparison with HSA, HSA-PMEMA nanomicelles exhibit improved cellular uptake and higher loading efficiency for PTX, effectively promoting the intracellular delivery of PTX. Tremendous potential lies in these micelles for developing safer and more efficient next-generation PTX formulations for tumor treatment.

Schlagwörter

Stichwörter der Autor:innen

nanoparticlepaclitaxelprotein–polymer conjugateself-assembly

Autor:innen und Institutionen

  • Institute of Medical Technology, Peking University Health Science Center, Beijing 100191, China.
  • Central Laboratory, NMPA Key Laboratory for Dental Materials, National Engineering Research Center of Oral Biomaterials and Digital Medical Devices, Peking University School and Hospital of Stomatology, Beijing 100081,…

ORCID-Profile: Xuliang Deng, Xinyu Liu

Förderung

  • National Key R&D Program of China
  • NSFC/China
  • Clinical Medicine Plus X - Young Scholars Project, Peking University, the Fundamental Research Funds for the Central Universities
  • National Key R&D Program of China
  • Peking University

Zitieren

APA

Chen, Y., Liang, S., Chen, B., Jiao, F., Deng, X., & Liu, X. (2025). Novel HSA-PMEMA Nanomicelles Prepared via Site-Specific In Situ Polymerization-Induced Self-Assembly for Improved Intracellular Delivery of Paclitaxel. Pharmaceutics, 17(3), 316. https://doi.org/10.3390/pharmaceutics17030316

Vancouver

Chen Y, Liang S, Chen B, Jiao F, Deng X, Liu X. Novel HSA-PMEMA Nanomicelles Prepared via Site-Specific In Situ Polymerization-Induced Self-Assembly for Improved Intracellular Delivery of Paclitaxel. Pharmaceutics. 2025;17(3):316. doi:10.3390/pharmaceutics17030316

BibTeX
@article{Chen2025,
  author = {Chen, Yang and Liang, Shuang and Chen, Binglin and Jiao, Fei and Deng, Xuliang and Liu, Xinyu},
  title = {Novel HSA-PMEMA Nanomicelles Prepared via Site-Specific In Situ Polymerization-Induced Self-Assembly for Improved Intracellular Delivery of Paclitaxel},
  journal = {Pharmaceutics},
  year = {2025},
  volume = {17},
  number = {3},
  pages = {316},
  doi = {10.3390/pharmaceutics17030316}
}
Kostenlos starten →